Literature DB >> 22505363

Variant Creutzfeldt-Jakob disease: an update.

James W Ironside1.   

Abstract

Variant Creutzfeldt-Jakob disease (vCJD) is a novel human prion disease caused by the bovine spongiform encephalopathy agent. Most cases have occurred in the UK, with smaller numbers in 11 other countries. All definite vCJD cases have occurred in methionine homozygotes at codon 129 in the prion protein gene. Following oral infection, the vCJD agent appears to replicate in lymphoid tissues during the asymptomatic phase of the incubation period. At present, four probable cases of vCJD infection have been identified following transfusion of red blood cells from asymptomatic donors who subsequently died from vCJD. Recently, one case of likely transmission of vCJD infection by UK Factor VIII concentrates has been reported in an elderly haemophilic patient in the UK. The recent report of a blood test that may be used to detect vCJD has raised the possibility of a new way to identify infected individuals, perhaps even before the onset of clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505363

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  16 in total

1.  Variant Creutzfeldt-Jakob disease deferral in Canada: impact of stop dates.

Authors:  Sheila F O'brien; Wenli Fan; Qi-Long Yi; Samra Uzicanin; Lori Osmond; Mindy Goldman
Journal:  Blood Transfus       Date:  2016-12-15       Impact factor: 3.443

2.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

3.  Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies.

Authors:  Dylana Díaz-Solano; Jaheli Fuenmayor; Ramon F Montaño
Journal:  Blood Transfus       Date:  2017-05-30       Impact factor: 3.443

Review 4.  The risk of Creutzfeldt-Jakob disease infection in cadaveric surgical training.

Authors:  Keiko Ogami-Takamura; Kazunobu Saiki; Daisuke Endo; Kiyohito Murai; Toshiyuki Tsurumoto
Journal:  Anat Sci Int       Date:  2022-03-21       Impact factor: 1.741

Review 5.  Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Authors:  David J Bonda; Sunil Manjila; Prachi Mehndiratta; Fahd Khan; Benjamin R Miller; Kaine Onwuzulike; Gianfranco Puoti; Mark L Cohen; Lawrence B Schonberger; Ignazio Cali
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

Review 6.  Prion Diseases.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2015-12

Review 7.  Variant CJD. 18 years of research and surveillance.

Authors:  Abigail B Diack; Mark W Head; Sandra McCutcheon; Aileen Boyle; Richard Knight; James W Ironside; Jean C Manson; Robert G Will
Journal:  Prion       Date:  2014-11-01       Impact factor: 3.931

Review 8.  Genetics of prion diseases.

Authors:  Sarah E Lloyd; Simon Mead; John Collinge
Journal:  Curr Opin Genet Dev       Date:  2013-03-19       Impact factor: 5.578

9.  Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996.

Authors:  Chu-Chih Chen; Yin-Han Wang
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

Review 10.  Synaptic dysfunction in prion diseases: a trafficking problem?

Authors:  Assunta Senatore; Elena Restelli; Roberto Chiesa
Journal:  Int J Cell Biol       Date:  2013-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.